Radiofrequency ablation of small hepatocellular carcinoma with intravenous pegylated liposomal doxorubicin

Hepatology International

Volumn 5, Issue 1, 2011, Pages 567-574

  Wang, Jing Houng ^a   Tung, Hung Da ^b   Chen, Tai Yi ^a   Hung, Chao Hung ^a   Chen, Chien Hung ^a   Changchien, Chi Sin ^a   Hu, Tsung Hui ^a   Lee, Chuan Mo ^a   Lu, Sheng Nan ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b CHI MEI FOUNDATION HOSPITAL   (Taiwan)

Author keywords

Hepatocellular carcinoma; Pegylated liposomal doxorubicin; Radiofrequency ablation

Indexed keywords

ALPHA FETOPROTEIN; DOXORUBICIN;

ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER GROWTH; CANCER SIZE; CANCER SURVIVAL; CAUSE OF DEATH; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE EXACERBATION; DRUG EFFICACY; ESOPHAGUS VARICES BLEEDING; FEMALE; FOLLOW UP; HEPATITIS B; HISTOPATHOLOGY; HUMAN; LIVER CELL CARCINOMA; LIVER FAILURE; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIOFREQUENCY ABLATION; SEPTIC SHOCK; SURVIVAL RATE; TUMOR DIFFERENTIATION; TUMOR VOLUME;

EID: 79952627632     PISSN: 19360533     EISSN: 19360541     Source Type: Journal    
DOI: 10.1007/s12072-010-9215-1     Document Type: Article

References (28)

1. GD Dodd III MC Soulen RA Kane T Livraghi WR Lees Y Yamashita, et al. 2000 Minimally invasive treatment of malignant hepatic tumors: at the threshold of a major breakthrough Radiographics 20 9 27 10682768
2. JP McGahan GD Dodd III 2001 Radiofrequency ablation of the liver: current status Am J Roentgenol 176 3 16 (Pubitemid 32012850)
3. RA Lencioni HP Allgaier D Cioni M Olschewski P Deibert L Crocetti, et al. 2003 Small hepatocellular carcinoma in cirrhosis: randomized comparison of radiofrequency thermal ablation versus percutaneous ethanol injection Radiology 228 235 240 10.1148/radiol.2281020718 12759473 (Pubitemid 36736097)
4. SM Lin CJ Lin CC Lin CW Hsu YC Chen 2004 Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma ≦4 cm Gastroenterology 127 1714 1723 10.1053/j.gastro.2004.09.003 15578509 (Pubitemid 39575850)
5. S Shiina T Teratani S Obi S Sato R Tateishi T Fujishima, et al. 2005 Randomized controlled trial of radiofrequency with ethanol injection for small hepatocellular carcinoma Gastroenterology 129 122 130 10.1053/j.gastro.2005.04. 009 16012942 (Pubitemid 41002049)
6. YK Cho JK Kim MY Kim H Rhim JK Han 2009 Systemic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies Hepatology 49 453 459 10.1002/hep.22648 19065676
7. T Livraghi F Meloni SN Goldberg S Lazzaroni L Solbiati GS Gazelle 2000 Hepatocellular carcinoma: radiofrequency ablation of medium and large lesions Radiology 214 761 768 1:STN:280:DC%2BD3c7osV2gsQ%3D%3D 10715043 (Pubitemid 30115377)
8. SN Goldberg GS Gazelle 2001 Radiofrequency tissue ablation: physical principles and techniques for increasing coagulation necrosis Hepatogastroenterology 48 359 367 1:STN:280:DC%2BD3M3psVSrsg%3D%3D 11379309 (Pubitemid 32391567)
9. YJ Zhang HH Liang MS Chen RP Guo JQ Li Y Zheng, et al. 2007 Hepatocellular carcinoma treated with radiofrequency ablation with or without ethanol injection: a prospective randomized control trial Radiology 44 599 607 1:CAS:528:DC%2BD1cXht1aktbnE 10.1148/radiol.2442060826 (Pubitemid 47080894)
10. H Kirikoshi S Saito M Yoneda K Fujita H Mawatari T Uchiyama, et al. 2009 Outcome of transarterial chemoembolization monotherapy, and in combination with percutaneous ethanol injection or radiofrequency ablation therapy for hepatocellular carcinoma Hepatol Res 39 553 562 1:CAS:528:DC%2BD1MXhtF2isrjL 10.1111/j.1872-034X.2009.00490.x 19527484
11. T Livraghi SN Goldberg F Monti A Bizzini S Lazzaroni F Meloni, et al. 1997 Saline-enhanced radiofrequency tissue ablation in the treatment of liver metastasis Radiology 202 205 210 1:STN:280:DyaK2s7ktF2lsA%3D%3D 8988212 (Pubitemid 27024128)
12. SN Goldberg M Ahmed GS Gazelle JB Kruskal JC Huertas EF Halpern, et al. 2001 Radio-frequency thermal ablation with NaCl solution injection: effect of electrical conductivity on tissue heating and coagulation-phantom and porcine liver study Radiology 219 157 165 1:STN:280:DC%2BD3M7oslKhuw%3D%3D 11274551 (Pubitemid 32234068)
13. JB Kruskal B Oliver JC Huertas SN Goldberg 2001 Dynamic intrahepatic flow and cellular alterations during radiofrequency ablation of liver tissue in mice J Vasc Interv Radiol 12 1193 1202 1:STN:280:DC%2BD3MrjvFajsA%3D%3D 10.1016/S1051-0443(07)61679-0 11585886
14. JMC Bull 1984 An update on the anticancer effects of a combination of chemotherapy and hyperthermia Cancer Res 44 4853s 4856s 1:STN:280: DyaL2c3ot1Chug%3D%3D 6205752 (Pubitemid 14000106)
15. A Ahmed SN Goldberg 2004 Combination radiofrequency thermal ablation and adjuvant IV liposomal doxorubicin increases tissue coagulation and intratumoral drug accumulation Int J Hypertermia 20 781 802 1:CAS:528:DC%2BD2cXhtVahtr7I 10.1080/02656730410001711655 (Pubitemid 39496856)
16. SN Goldberg JR Kamel JB Kruskal K Reynolds WL Monsky KE Stuart, et al. 2002 Radiofrequency ablation of hepatic tumors: increased tumor destruction with adjuvant liposomal doxorubicin therapy Am J Roentgenol 179 93 101 (Pubitemid 34694817)
17. J Dvorak Z Zoul B Melichar P Jandik J Mergancova I Motvckova, et al. 2002 Pegylated liposomal doxorubicin in combination with hyperthermia in the treatment of a case of advanced hepatocellular carcinoma J Clin Gastroenterol 34 96 98 10.1097/00004836-200201000-00020 11743256 (Pubitemid 34038490)
18. DM Vail MA Amantea GT Colbem FJ Martin RA Hilger PK Working 2004 Pegylated liposomal doxorubicin: proof of principle using preclinical animal models and pharmacokinetic studies Semin Oncol 31 suppl 13 16 35 1:CAS:528:DC%2BD2MXhtVyns7k%3D 10.1053/j.seminoncol.2004.08.002 15717736 (Pubitemid 40023240)
19. JW Valle A Dangoor J Beech DJ Sherlock SM Lee JH Scarffe, et al. 2005 Treatment of inoperable hepatocellular carcinoma with pegylated liposomal doxorubicin (PLD): results of a phase II study Br J Cancer 92 628 630 1:CAS:528:DC%2BD2MXhsFWltLw%3D 10.1038/sj.bjc.6602394 15700038 (Pubitemid 40460594)
20. M Morimoto K Sugimori K Shirato A Kokawa N Tomita T Saito, et al. 2002 Treatment of hepatocellular carcinoma with radiofrequency ablation: radiologic-histologic correlation during follow-up periods Hepatology 35 1467 1475 10.1053/jhep.2002.33635 12029632 (Pubitemid 34966901)
21. E Blanco F Qian B Weinberg N Stowe JM Anderson J Gao 2004 Effect of fibrous capsule formation on doxorubicin distribution in radiofrequency ablated rat livers J Biomed Mater Res A 69 398 406 10.1002/jbm.a.30001 15127386 (Pubitemid 38668165)
22. R Lencioni L Crocetti P Petruzzi C Vignali E Bozzi CD Pina, et al. 2008 Doxorubicin-eluting bead-enhanced radiofrequency ablation of hepatocellular carcinoma: a pilot clinical study J Hepatol 49 217 222 1:CAS:528: DC%2BD1cXotlWqtr4%3D 10.1016/j.jhep.2008.03.021 18486261
23. HD Han MS Choi MS Hwang CK Song H Seong TW Kim, et al. 2006 Hyperthermia-induced antitumor activity of thermosensitive polymer modified temperature-sensitive liposomes J Pharm Sci 95 1909 1917 1:CAS:528: DC%2BD28XpsFehtLo%3D 10.1002/jps.20646 16795016 (Pubitemid 44433023)
24. AR Gillams WR Lees 2008 Five-year survival following radiofrequency ablation of small, solitary, hepatic colorectal metastases J Vasc Interv Radiol 19 712 717 10.1016/j.jvir.2008.01.016 18440460
25. A Suppiah TJ White SH Rov-Choudhury DJ Breen J Cast A Maravevas, et al. 2007 Long-term results of percutaneous radiofrequency ablation of unresectable colorectal hepatic metastasis: final outcomes Dig Surg 24 358 360 1:STN:280:DC%2BD2srovFaguw%3D%3D 10.1159/000107717 17785980 (Pubitemid 47519245)
26. MS Chen JQ Li Y Zheng RP Guo HH Liang YQ Zhang, et al. 2006 A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma Ann Surg 243 321 328 10.1097/01.sla.0000201480.65519.b8 16495695 (Pubitemid 43327762)
27. M Ahmed AN Lukyanov V Torchilin H Tournier AN Schneider SN Goldberg 2005 Combined radiofrequency ablation and adjuvant liposomal chemotherapy: effect of chemotherapeutic agent, nanoparticle size, and circulation time J Vas Inter Radiol 16 1365 1371 (Pubitemid 41463995)
28. G D'lppolito M Ahmed GD Girnun KE Stuart JB Kruskal EF Halpern, et al. 2003 Percutaneous tumor ablation: reduced tumor growth with combined radio-frequency ablation and liposomal doxorubicin in a rat breast tumor model Radiology 228 112 118 10.1148/radiol.2281020358 (Pubitemid 36736077)